Innovent Biologics Inc - Company Profile
Powered by 
All the data and insights you need on Innovent Biologics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Innovent Biologics Inc Strategy Report
- Understand Innovent Biologics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Innovent Biologics Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 04 Aug 2022 | Innovent Biologics Enters into Licensing Agreement with Sanofi | Licensing Agreement |
Innovent Biologics Inc
|
Sanofi |
| 03 Aug 2022 | Innovent Biologics to Raise USD305 Million in Private Placement of Shares | Equity Offering |
Sanofi
|
Innovent Biologics Inc |
| 27 Mar 2022 | Innovent Biologics Enters into Agreement with Eli Lilly | Partnership | - |
Eli Lilly and Co Innovent Biologics Inc |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer